{"transactions":[{"id":1870040,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-06-02T07:52:35.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40000,"derivative":{"exercise_price":0.3025,"exercise_date":"2023-05-23","expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-23-045385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390023045385/ownership.xml","form_type":"4"}},{"id":2372187,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option","published_at":"2022-02-25T15:18:31.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022."}],"balance_after":35000,"derivative":{"exercise_price":2,"exercise_date":"2022-03-23","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-22-009451","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390022009451/ownership.xml","form_type":"4"}},{"id":2547222,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Warrant","published_at":"2021-10-06T17:22:19.000Z","date":"2021-10-04","kind":"other","acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 4, 2021, Dr. Johnson sold warrants to purchase 150,000 shares of the issuer's common stock pursuant to the SPA, for an aggregate purchase price of $1,500. The warrants provide for an exercise price of $6.25 per share and expire five years after issuance."}],"balance_after":39714,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-21-051646","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390021051646/ownership.xml","form_type":"4"}},{"id":2547221,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-10-06T17:22:19.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":200000,"ownership":{"direct":false,"nature":"By En Fideicomiso De Mi Vida 11/23/2010 (Trust)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"En Fideicomiso De Mi Vida 11/23/2010 (the \"Trust\") sold 200,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of October 1, 2021 (the \"SPA\"), for an aggregate purchase price of $200,000."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"En Fideicomiso De Mi Vida 11/23/2010 (the \"Trust\") sold 200,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of October 1, 2021 (the \"SPA\"), for an aggregate purchase price of $200,000."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Johnson is the trustee of the Trust."}],"balance_after":148246,"source":{"system":"sec-edgar","filing":"0001213900-21-051646","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390021051646/ownership.xml","form_type":"4"}},{"id":2752988,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-08T21:47:32.000Z","date":"2021-04-06","kind":"sale","acquired":false,"shares":150000,"price":2.5,"value":375000.0,"ownership":{"direct":false,"nature":"En Fideicomiso De Mi Vida 11/23/2010 (Trust)"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold 150,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of April 6, 2021 for an aggregate purchase price of $375,000."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Dr. Johnson is the trustee of each of these trusts."}],"balance_after":548336,"source":{"system":"sec-edgar","filing":"0001213900-21-020918","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390021020918/ownership.xml","form_type":"4"}},{"id":3048807,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-08-24T16:59:08.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":350000,"price":1.21,"value":423500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold 350,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of August 19, 2020 for an aggregate purchase price of $425,000."}],"balance_after":1055,"source":{"system":"sec-edgar","filing":"0001213900-20-023494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390020023494/ownership.xml","form_type":"4"}},{"id":3342332,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-13T21:00:40.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":150000,"price":1,"value":150000.0,"ownership":{"direct":false,"nature":"En Fideicomiso De Mi Vida 11/23/2010 (Trust)"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Johnson is the trustee of each of these trusts."}],"balance_after":698336,"source":{"system":"sec-edgar","filing":"0001213900-19-026186","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390019026186/ownership.xml","form_type":"4"}},{"id":3397417,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-10-04T17:01:05.000Z","date":"2019-10-02","kind":"grant","acquired":true,"shares":3187,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":351055,"source":{"system":"sec-edgar","filing":"0001213900-19-019766","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390019019766/ownership.xml","form_type":"4"}},{"id":3572097,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-01T16:57:44.000Z","date":"2019-03-29","kind":"purchase","acquired":true,"shares":600,"price":3.2967,"value":1978.02,"ownership":{"direct":true},"balance_after":347868,"source":{"system":"sec-edgar","filing":"0001213900-19-005524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390019005524/ownership.xml","form_type":"4"}},{"id":3572096,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-01T16:57:44.000Z","date":"2019-03-29","kind":"purchase","acquired":true,"shares":2500,"price":3.4676,"value":8669.0,"ownership":{"direct":true},"balance_after":347268,"source":{"system":"sec-edgar","filing":"0001213900-19-005524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390019005524/ownership.xml","form_type":"4"}},{"id":3572095,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-01T16:57:44.000Z","date":"2019-03-29","kind":"purchase","acquired":true,"shares":30000,"price":3.4718,"value":104154.0,"ownership":{"direct":true},"balance_after":344768,"source":{"system":"sec-edgar","filing":"0001213900-19-005524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390019005524/ownership.xml","form_type":"4"}},{"id":3572094,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-01T16:57:44.000Z","date":"2019-03-28","kind":"purchase","acquired":true,"shares":40000,"price":3.1452,"value":125808.0,"ownership":{"direct":true},"balance_after":314768,"source":{"system":"sec-edgar","filing":"0001213900-19-005524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390019005524/ownership.xml","form_type":"4"}},{"id":3578508,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2019-03-26T09:15:22.000Z","date":"2019-03-24","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis over 36 months."}],"balance_after":250000,"derivative":{"exercise_price":3.01,"exercise_date":"2019-04-24","expiration_date":"2029-03-23","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001213900-19-004830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390019004830/ownership.xml","form_type":"4"}},{"id":3767142,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-11-13T18:01:18.000Z","date":"2018-11-12","kind":"other","acquired":true,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock."}],"balance_after":17600,"derivative":{"exercise_price":6.25,"exercise_date":"2018-11-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001213900-18-015546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018015546/ownership.xml","form_type":"4"}},{"id":3767141,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-11-13T18:01:18.000Z","date":"2018-11-12","kind":"other","acquired":true,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock."}],"balance_after":17600,"derivative":{"exercise_price":5,"exercise_date":"2018-11-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001213900-18-015546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018015546/ownership.xml","form_type":"4"}},{"id":3767140,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase units","published_at":"2018-11-13T18:01:18.000Z","date":"2018-11-12","kind":"other","acquired":false,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":5,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Units","underlying_shares":35200},"source":{"system":"sec-edgar","filing":"0001213900-18-015546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018015546/ownership.xml","form_type":"4"}},{"id":3855114,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2018, Dr. Johnson purchased 1,400 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 31, 2018, Dr. Johnson purchased 1,400 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."}],"balance_after":169314,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855113,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase units","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The warrant to purchase 17,600 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 35,200 shares."}],"balance_after":17600,"derivative":{"exercise_price":5,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Units","underlying_shares":35200},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855112,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":153114,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."}],"balance_after":170714,"derivative":{"exercise_price":6.25,"underlying":"Common Stock","underlying_shares":153114},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855111,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to purchase common stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"A warrant to purchase 17,600 shares of common stock was issued upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."}],"balance_after":17600,"derivative":{"exercise_price":6.25,"exercise_date":"2018-07-31","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855110,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"exercise","acquired":false,"shares":153114,"price":0.44,"value":67370.16,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."}],"balance_after":0,"derivative":{"exercise_price":0.44,"underlying":"Common Stock","underlying_shares":153114},"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855109,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":40382,"ownership":{"direct":false,"nature":"Medico-Trans Company, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The 40,382 shares were received upon consummation of the initial public offering in accordance with a Services Agreement with Medico-Trans Company, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The 40,382 shares were received upon consummation of the initial public offering in accordance with a Services Agreement with Medico-Trans Company, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Medico-Trans Company, LLC is controlled by Bankole Johnson."}],"balance_after":313750,"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855108,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"purchase","acquired":true,"shares":1400,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"On July 31, 2018, Dr. Johnson purchased 1,400 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 31, 2018, Dr. Johnson purchased 1,400 units (the \"Units\") in the initial public offering at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant. Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the initial public offering."}],"balance_after":1400,"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855107,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"other","acquired":true,"shares":17600,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The 17,600 shares were received upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The 17,600 shares were received upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018."}],"balance_after":273368,"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}},{"id":3855106,"issuer":{"id":7742,"kind":"organization","name":"ADIAL PHARMACEUTICALS, INC.","symbol":"ADIL"},"owners":[{"id":112814,"kind":"person","name":"Johnson Bankole A.","position":1,"cik":"0001718158","reported_name":"Johnson Bankole A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":164573,"kind":"organization","name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","position":2,"cik":"0001719033","reported_name":"En Fidecomiso de Mi Vida 11/23/2010 Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-02T16:08:21.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":153114,"price":0.44,"value":67370.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 153,114 shares of common stock and a warrant to purchase 153,114 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $52,000 together with interest accrued thereon at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018."}],"balance_after":255768,"source":{"system":"sec-edgar","filing":"0001213900-18-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718158/000121390018010087/ownership.xml","form_type":"4"}}]}